Výsledky vyhledávání

Akademický článek

Clinical applicability and cost of a 46-gene panel for genomic analysis of solid tumours: Retrospective validation and prospective audit in the UK National Health Service.

Autor: Angela Hamblin, Sarah Wordsworth, Jilles M Fermont, Suzanne Page, Kulvinder Kaur, Carme Camps, Pamela Kaisaki, Avinash Gupta, Denis Talbot, Mark Middleton, Shirley Henderson, Anthony Cutts, Dimitrios V Vavoulis, Nick Housby, Ian Tomlinson, Jenny C Taylor, Anna Schuh

Publikováno v: PLoS Medicine, Vol 14, Iss 2, p e1002230 (2017)

BackgroundSingle gene tests to predict whether cancers respond to specific targeted therapies are performed increasingly often. Advances in sequencing technology, collectively referred to as next generation sequencing (NGS), mean the entire cancer ge

Externí odkaz: https://doaj.org/article/30d53926b96445d9a9f524a7a39674d7

Zobrazit plný text záznamu

Clinical applicability and cost of a 46-gene panel for genomic analysis of solid tumours: Retrospective validation and prospective audit in the UK National Health Service

Autor: Angela, Hamblin, Sarah, Wordsworth, Jilles M, Fermont, Suzanne, Page, Kulvinder, Kaur, Carme, Camps, Pamela, Kaisaki, Avinash, Gupta, Denis, Talbot, Mark, Middleton, Shirley, Henderson, Anthony, Cutts, Dimitrios V, Vavoulis, Nick, Housby, Ian, Tomlinson, Jenny C, Taylor, Anna, Schuh

Publikováno v: PLoS Medicine, Vol 14, Iss 2, p e1002230 (2017)
PLoS Medicine

Background Single gene tests to predict whether cancers respond to specific targeted therapies are performed increasingly often. Advances in sequencing technology, collectively referred to as next generation sequencing (NGS), mean the entire cancer g

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::6032383a8d73172aa0f15760e1e5db6a
https://ora.ox.ac.uk/objects/uuid:885a2715-5860-4ad3-bf89-31a4143ec52f

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání